| Carla Mccormack, RN | |
|
2444 Main St, Bethlehem, NH 03574-4916 | |
| (603) 869-0087 | |
| Not Available |
| Full Name | Carla Mccormack |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 2444 Main St, Bethlehem, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932688801 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 070417-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carla Mccormack, RN 14 Wentworth St, Plymouth, NH 03264-1428 Ph: (603) 960-2968 | Carla Mccormack, RN 2444 Main St, Bethlehem, NH 03574-4916 Ph: (603) 869-0087 |
News Archive
Cardiff University scientists have developed a novel anti-cancer stem cell agent capable of targeting aggressive tumour forming cells common to breast, pancreas, colon and prostate cancers.
Researchers at the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins have invented a cost-effective and highly efficient way of analyzing what many have termed "junk" DNA and identified regions critical for controlling gene function.
CRISPR/Cas9 is now a household name associated with genetic engineering studies.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.
› Verified 3 days ago
Rhonda Connors, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2444 Main St, Bethlehem, NH 03574 Phone: 603-869-0911 |